Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)
Completed
- Conditions
- Hyperkalemia Elevated Plasma K+ Cardiovascular Disease (CVD)
- Registration Number
- NCT03657875
- Lead Sponsor
- AstraZeneca
- Brief Summary
This is a cross-sectional retrospective study of laboratory records of patients who take electrolytes blood tests containing the data of the serum potassium level. This study is an observational one, and there is no intervention into routine clinical practice either in terms of therapy, or special examinations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 53940
Inclusion Criteria
- Males and females tested in the Russian centres of INVITRO laboratory from 01.01.2015 till 31.12.2016;
- 18 years and older;
- Available electrolytes blood test containing of the serum potassium level of the unique patient fits for interpretation.
Exclusion Criteria
- Blood test cannot be interpreted due to various reasons.
- Blood samples with sing of hemolysis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/L One day To determine the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/L based on INVITRO laboratory database during 2015-2016 years.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Invitro
🇷🇺Moscow, Russian Federation